Sangamo Therapeutics, Inc. (SGMOQ)
OTCMKTS · Delayed Price · Currency is USD
0.1150
-0.0020 (-1.71%)
Nov 4, 2026, 3:22 PM EST
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of $47.64 million as of November 4, 2026. It is the 30,146th most valuable company in the world and the 4,616th biggest in the United States. Its market cap has decreased by 72.69% in one year.
Market Cap
47.64M
Enterprise Value
39.39M
Revenue
34.56M
Global Rank
Country Rank
#4,616 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has decreased from 92.36M to 47.64M, a decrease of -48.42%. That is a compound annual growth rate of -2.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 47.64M | -66.29% |
| Dec 31, 2025 | 141.33M | -33.59% |
| Dec 31, 2024 | 212.82M | 120.88% |
| Dec 29, 2023 | 96.35M | -81.28% |
| Dec 30, 2022 | 514.58M | -52.90% |
| Dec 31, 2021 | 1.09B | -50.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ProText Mobility | 67.43M |
| Nuo Therapeutics | 61.51M |
| Arch Biopartners | 38.72M |
| ZIVO Bioscience | 38.40M |
| Cell Source | 36.45M |
| Provectus Biopharmaceuticals | 20.93M |
| Biomind Labs | 19.41M |
| Vicapsys Life Sciences | 16.19M |